{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:33:55Z","timestamp":1759336435044,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T00:00:00Z","timestamp":1502236800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This study was partially supported by the statutory funds from the Medical University of Lodz, Poland","award":["No. 503\/1-107-03\/503-01"],"award-info":[{"award-number":["No. 503\/1-107-03\/503-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s12020-017-1366-6","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T07:38:19Z","timestamp":1502264299000},"page":"474-480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Copeptin as a marker of an altered CRH axis in pituitary disease"],"prefix":"10.1007","volume":"57","author":[{"given":"Krzysztof C.","family":"Lewandowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Lewi\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Skowro\u0144ska-J\u00f3\u017awiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Malicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Horzelski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8532-7632","authenticated-orcid":false,"given":"Georg","family":"Brabant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,9]]},"reference":[{"key":"1366_CR1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1046\/j.1365-2265.1998.00610.x","volume":"49","author":"SM Orme","year":"1998","unstructured":"S.M. Orme, A. Price, A.P. Weetman, R.J. Ross, Comparison of the diagnostic utility of the simplified and standard i.m. glucagon stimulation test (IMGST). Clin. Endocrinol. 49, 773\u2013778 (1998)","journal-title":"Clin. Endocrinol."},{"key":"1366_CR2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/jcp.19.3.284","volume":"19","author":"FC Greenwood","year":"1966","unstructured":"F.C. Greenwood, J. Landon, Assessment of hypothalamic pituitary function in endocrine disease. J. Clin. Pathol. 19, 284\u2013292 (1966)","journal-title":"J. Clin. Pathol."},{"key":"1366_CR3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0196-9781(83)90041-4","volume":"4","author":"FA Antoni","year":"1983","unstructured":"F.A. Antoni, M.C. Holmes, M.T. Jones, Oxytocin as well as vasopressin potentiate ovine CRF in vitro. Peptides 4, 411\u2013415 (1983)","journal-title":"Peptides"},{"key":"1366_CR4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1006\/frne.1993.1004","volume":"14","author":"FA Antoni","year":"1993","unstructured":"F.A. Antoni, Vasopressinergic control of pituitary adrecorticotropin secretion comes of age. Front. Neuroendocrinol. 14, 76\u2013122 (1993)","journal-title":"Front. Neuroendocrinol."},{"key":"1366_CR5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0079-6123(08)00403-2","volume":"170","author":"G Aguilera","year":"2008","unstructured":"G. Aguilera, S. Subburaju, S. Young, J. Chen, The parvocellular vasopressinergic system and responsiveness of the hypothalamic pituitary adrenal axis during chronic stress. Prog. Brain Res. 170, 29\u201339 (2008)","journal-title":"Prog. Brain Res."},{"key":"1366_CR6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-0115(00)00196-8","volume":"96","author":"G Aguilera","year":"2000","unstructured":"G. Aguilera, C. Rabadan-Diehl, Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul. Pept. 96, 23\u201329 (2000)","journal-title":"Regul. Pept."},{"key":"1366_CR7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1210\/endo-125-1-28","volume":"125","author":"F Berkenbosch","year":"1989","unstructured":"F. Berkenbosch, D.C. de Goeij, F.J. Tilders, Hypoglycaemia enhances turnover of corticotrophin-releasing factor and of vasopressin in the zona externa of the rat median eminence. Endocrinology 125, 28\u201334 (1989)","journal-title":"Endocrinology"},{"key":"1366_CR8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000125141","volume":"49","author":"D Engler","year":"1989","unstructured":"D. Engler, T. Pham, M.J. Fullerton, G. Ooi, J.W. Funder, I.J. Clarke, Studies of the secretion of corticotrophin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. Effect of an audiovisual stimulus and insulin-induced hypoglycaemia. Neuroendocrinology 49, 367\u2013381 (1989)","journal-title":"Neuroendocrinology"},{"key":"1366_CR9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1677\/joe.0.1530401","volume":"153","author":"SL Alexander","year":"1997","unstructured":"S.L. Alexander, H.K. Roud, C.H. Irvine, Effect of insulin-induced hypoglycaemia on secretion patterns and rates of corticotrophin-releasing hormone, arginine vasopressin and adrenocorticotropin in horses. J. Endocrinol. 153, 401\u2013409 (1997)","journal-title":"J. Endocrinol."},{"issue":"2","key":"1366_CR10","doi-asserted-by":"crossref","first-page":"I129","DOI":"10.1161\/01.HYP.5.2_Pt_2.I129","volume":"5","author":"JJ Preibisz","year":"1983","unstructured":"J.J. Preibisz, J.E. Sealey, J.H. Laragh, R.J. Cody, B.B. Weksler, Plasma and platelet vasopressin in essential hypertension and congestive heart failure. Hypertension 5(2) part 2, I129\u2013I138 (1983)","journal-title":"Hypertension"},{"key":"1366_CR11","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1172\/JCI107423","volume":"52","author":"GL Roberston","year":"1973","unstructured":"G.L. Roberston, E.A. Mahr, S. Athar, T. Sinha, Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J. Clin. Invest. 52, 2340\u20132352 (1973)","journal-title":"J. Clin. Invest."},{"key":"1366_CR12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tem.2007.11.001","volume":"19","author":"NG Morgenthaler","year":"2008","unstructured":"N.G. Morgenthaler, J. Struck, S. Jochberger, M.W. D\u00fcnser, Copeptin: clinical use of a new biomarker. Trends Endocrinol. Metab. 19, 43\u201349 (2008)","journal-title":"Trends Endocrinol. Metab."},{"key":"1366_CR13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","volume":"52","author":"NG Morgenthaler","year":"2006","unstructured":"N.G. Morgenthaler, J. Struck, C. Alonso, A. Bergmann, Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin. Chem. 52, 112\u2013119 (2006)","journal-title":"Clin. Chem."},{"key":"1366_CR14","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1210\/jc.2014-2295","volume":"99","author":"R Roussel","year":"2014","unstructured":"R. Roussel, L. Fezeu, M. Marre, G. Velho, F. Fumeron, P. Jungers, O. Lantieri, B. Balkau, N. Bouby, L. Bankir, D.G. Bechet, Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease. J. Clin. Endocrinol. Metab. 99, 4656\u20134663 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1366_CR15","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1210\/jc.2014-4527","volume":"100","author":"B Winzeler","year":"2015","unstructured":"B. Winzeler, C. Zweifel, N. Nigro, B. Arici, M. Bally, P. Schuetz, C.A. Blum, C. Kelly, S. Berkmann, A. Huber, F. Gentili, G. Zadeh, H. Landolt, L. Mariani, B. M\u00fcller, M. Christ-Crain, Postoperative copeptin concentration predicts diabetes insipidus after pituitary surgery. J. Clin. Endocrinol. Metab. 100, 2275\u20132282 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1366_CR16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.beem.2016.02.003","volume":"30","author":"M Christ-Crain","year":"2016","unstructured":"M. Christ-Crain, N.G. Morgenthaler, W. Fenske, Copeptin as a biomarker and a diagnostic tool in the evaluation of patients with polyuria-polydipsia and hyponatremia. Best Pract. Res. Clin. Endocrinol. Metab. 30, 235\u2013247 (2016)","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"1366_CR17","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2006-2046","volume":"92","author":"M Katan","year":"2007","unstructured":"M. Katan, N.G. Morgenthaler, K.C. Dixit, J. Rutishauser, G.E. Brabant, B. M\u00fcller, M. Crist-Crain, Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay. J. Clin. Endocrinol. Metab. 92, 2640\u20132643 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1366_CR18","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/cen.12608","volume":"82","author":"S Kacheva","year":"2015","unstructured":"S. Kacheva, K. Kolk, N.G. Morgenthaler, G. Brabant, W. Karges, Gender-specific co activation of arginine vasopressin and the hypothalamic-pituitary-adrenal axis during stress. Clin. Endocrinol. 82, 570\u2013576 (2015)","journal-title":"Clin. Endocrinol."},{"key":"1366_CR19","doi-asserted-by":"crossref","first-page":"e72876","DOI":"10.1371\/journal.pone.0072876","volume":"8","author":"E Seelig","year":"2013","unstructured":"E. Seelig, S. Biltz, U. Keller, F. Meienberg, M. Crist-Crain, Concentrations of the stress hormone copeptin increase upon hypoglycaemia in patients with type 1 diabetes dependent of hypoglycaemia awareness. PLoS One 8, e72876 (2013)","journal-title":"PLoS One"},{"key":"1366_CR20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12020-015-0783-7","volume":"52","author":"K Lewandowski","year":"2016","unstructured":"K. Lewandowski, A. Lewinski, E. Skowronska-Jozwiak, M. Stasiak, W. Horzelski, G. Brabant, Copeptin under glucagon stimulation. Endocrine 52, 344\u2013351 (2016)","journal-title":"Endocrine"},{"key":"1366_CR21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1515\/JPEM.2005.18.5.433","volume":"18","author":"A B\u00f6ttner","year":"2005","unstructured":"A. B\u00f6ttner, J. Kratzsch, S. Liebermann, K. Alexandra, W.P. Roland, K. Wieland, K. Eberhard, Comparison of adrenal function tests in children\u2014the glucagon stimulation test allows the simultaneous assessment of adrenal function and growth hormone response in children. J. Pediatr. Endocrinol. Metab. 18, 433\u2013442 (2005)","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"1366_CR22","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/j.peptides.2005.04.019","volume":"26","author":"J Struck","year":"2005","unstructured":"J. Struck, N.G. Morgenthaler, A. Bergmann, Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides 26, 2500\u20132504 (2005)","journal-title":"Peptides"},{"key":"1366_CR23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2265.1995.tb02613.x","volume":"43","author":"WJ Inder","year":"1995","unstructured":"W.J. Inder, M.J. Ellis, M.J. Evans, R.A. Donald, A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal men. Clin. Endocrinol. 43, 425\u2013431 (1995)","journal-title":"Clin. Endocrinol."},{"key":"1366_CR24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1210\/endo-125-1-554","volume":"125","author":"GV Childs","year":"1989","unstructured":"G.V. Childs, K.N. Westlund, G. Unabia, Characterization of anterior pituitary target cells for arginine vasopressin: including cells that store adrenocorticotropin, thyrotropin-beta, and both hormones. Endocrinology 125, 554\u2013559 (1989)","journal-title":"Endocrinology"},{"key":"1366_CR25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1210\/mend-3-1-117","volume":"3","author":"GV Childs","year":"1989","unstructured":"G.V. Childs, G. Unabia, Activation of protein kinase C and L calcium channels enhances binding of biotinylated corticotrophin-releasing hormone by anterior pituitary corticotropes. Mol. Endocrinol. 3, 117\u2013126 (1989)","journal-title":"Mol. Endocrinol."},{"key":"1366_CR26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10571-006-9135-8","volume":"27","author":"SF Young","year":"2007","unstructured":"S.F. Young, C. Griffante, G. Aguilera, Dimerization between vasopressin V1b and corticotrophin releasing hormone type 1 receptors. Cell. Mol. Neurobiol. 27, 439\u2013461 (2007)","journal-title":"Cell. Mol. Neurobiol."},{"key":"1366_CR27","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1210\/jcem-66-4-668","volume":"66","author":"J Hensen","year":"1988","unstructured":"J. Hensen, O. Hader, V. B\u00e4hr, W. Oelkers, Effects of incremental infusions of arginine vasopressin on adrenocorticotropin and cortisol secretion in man. J. Clin. Endocrinol. Metab. 66, 668\u2013671 (1988)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1366_CR28","first-page":"183","volume":"43","author":"PW Gold","year":"1987","unstructured":"P.W. Gold, M.A. Kling, I. Khan, J.R. Calabrese, K. Kalogeras, R.M. Post, P.C. Avgerinos, D.L. Loriaux, G.P. Chrousos, Corticotropin releasing hormone: relevance to normal physiology and to pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency. Adv. Biochem. Psychopharmacol. 43, 183\u2013200 (1987)","journal-title":"Adv. Biochem. Psychopharmacol."},{"key":"1366_CR29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/eje.0.1430099","volume":"143","author":"E Arvat","year":"2000","unstructured":"E. Arvat, B. Maccagno, J. Ramunni, M. Maccario, R. Giordano, F. Broglio, F. Camanni, E. Ghigo, Interaction between glucagon and human corticotrophin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans. Eur. J. Endocrinol. 143, 99\u2013104 (2000)","journal-title":"Eur. J. Endocrinol."},{"key":"1366_CR30","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1113\/jphysiol.2015.284471","volume":"593","author":"PJ Duncan","year":"2015","unstructured":"P.J. Duncan, S. Seng\u00fcl, J. Tabak, P. Ruth, R. Bertram, M.J. Shipston, Large conductance Ca (2+)-activated K (+) (BK) channels promote secretagogue-induced transition from spiking to bursting in murine anterior pituitary corticotrphs. J. Physiol. 593, 1197\u20131211 (2015)","journal-title":"J. Physiol."},{"key":"1366_CR31","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1210\/en.2016-1115","volume":"157","author":"PJ Duncan","year":"2016","unstructured":"P.J. Duncan, J. Tabak, P. Ruth, R. Bertram, M.J. Shipston, Glucocorticoids inhibit CRH\/AVP-evoked bursting activity of male murine anterior pituitary corticotrphs. Endocrinology 157, 3108\u20133121 (2016)","journal-title":"Endocrinology"},{"key":"1366_CR32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.psyneuen.2016.11.006","volume":"76","author":"C Demiralay","year":"2017","unstructured":"C. Demiralay, A. Agorastos, A. Yassouritdis, H. Jahn, K. Wiedemann, M. Keller, Copeptin\u2014A potential endocrine surrogate marker of CCK-4-induced panic symptoms? Psychoneuroendocrinology 76, 14\u201318 (2017)","journal-title":"Psychoneuroendocrinology"},{"key":"1366_CR33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF03350005","volume":"12","author":"P Chiodera","year":"1989","unstructured":"P. Chiodera, A. Gnudi, L. Bianconi, L. Camellini, G. Rossi, P. Muzzetto, F. Fagnoni, L. Schianchi, R. Volpi, V. Coiro, The infusion of somatostatin reduces the arginine-vasopressin response to insulin-induced hypoglycemia in man. J. Endocrinol. Invest. 12, 349\u2013353 (1989)","journal-title":"J. Endocrinol. Invest."},{"key":"1366_CR34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01244458","volume":"83","author":"P Chiodera","year":"1991","unstructured":"P. Chiodera, V. Coiro, Endogenous opioid mediation of somatostatin inhibition of arginine vasopressin release evoked by insulin-induced hypoglycemia in man. J. Neural. Transm. Gen. Sect. 83, 121\u2013126 (1991)","journal-title":"J. Neural. Transm. Gen. Sect."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-017-1366-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1366-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1366-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T04:42:10Z","timestamp":1503895330000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-017-1366-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,9]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["1366"],"URL":"https:\/\/doi.org\/10.1007\/s12020-017-1366-6","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"type":"print","value":"1355-008X"},{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2017,8,9]]}}}